Suppression of presbyopia progression with pirenoxine eye drops: experiments on rats and non-blinded, randomized clinical trial of efficacy
Abstract Various methods can correct presbyopia, but all require devices or surgeries. Recently, supplements or warming devices to relieve presbyopic symptoms have been developed, but no eye drops have been developed. We screened certain compounds possibly related to lens degeneration and identified...
Guardado en:
Autores principales: | Yukari Tsuneyoshi, Akihiro Higuchi, Kazuno Negishi, Kazuo Tsubota |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ae2ee3b299441e58924a373dd4666f8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Presbyopia developed earlier during the COVID-19 pandemic.
por: Kazuno Negishi, et al.
Publicado: (2021) -
Presbyopia developed earlier during the COVID-19 pandemic
por: Kazuno Negishi, et al.
Publicado: (2021) -
Glucose levels between the anterior chamber of the eye and blood are correlated based on blood glucose dynamics.
por: Toshihide Kurihara, et al.
Publicado: (2021) -
Monocaprin eye drop formulation to combat antibiotic resistant gonococcal blindness
por: Colin P. Churchward, et al.
Publicado: (2020) -
Comparison of novel lipid-based eye drops with aqueous eye drops for dry eye: a multicenter, randomized controlled trial
por: Simmons PA, et al.
Publicado: (2015)